Allspring Global Investments’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
24,187
+890
+4% +$8.4K ﹤0.01% 1606
2026
Q1
$194K Buy
23,297
+2,304
+11% +$19.8K ﹤0.01% 1613
2025
Q4
$217K Buy
20,993
+1,825
+10% +$19.1K ﹤0.01% 1566
2025
Q3
$176K Buy
+19,168
New +$137K ﹤0.01% 1560
2023
Q4
– Sell
-350
Closed -$3.19K – 2495
2023
Q3
$3.19K Sell
350
-1,270
-78% -$12.9K ﹤0.01% 2693
2023
Q2
$17.1K Sell
1,620
-2,469
-60% -$29.2K ﹤0.01% 2483
2023
Q1
$50K Buy
4,089
+3,248
+386% +$40.5K ﹤0.01% 2289
2022
Q4
$10.4K Sell
841
-19
-2% -$276 ﹤0.01% 2704
2022
Q3
$11K Buy
+860
New +$13.3K ﹤0.01% 2718

Other funds holding KURA

Allspring Global Investments's KURA Position: Q2 2026 in Review

Allspring Global Investments increased its Kura Oncology (KURA) stake by 3.8% in Q2 2026, buying an estimated $8.4K and bringing the position to 24,187 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Allspring Global Investments first reported a position in KURA in Q3 2022 and has held it in 9 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Allspring Global Investments held 24,187 shares of Kura Oncology worth $261K as of Q2 2026.
  • Allspring Global Investments bought 890 Kura Oncology shares in Q2 2026, an estimated $8.4K.
  • Kura Oncology made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1606 holding.
  • Allspring Global Investments first reported a position in Kura Oncology in Q3 2022 and has held it in 9 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.